CSBR logo

Champions Oncology (CSBR) Return On Equity

Annual ROE

-532.46%
-454.76%-585.28%

April 30, 2024

Summary

Performance

1-Year Change

-585.28%

3-Year Change

-9312.11%

5-Year Change

-4762.52%

15-Year Change

+75.33%

CSBR ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

4.85%
CSBR annual return on equity is higher than 4.85% of companies in Healthcare sector

High & Low

All-time High

69.62%
CSBR annual return on equity is currently -864.81% below its historical high of 69.62%

3-Year Low

-532.46%
CSBR annual return on equity is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Apr 30, 2024
CSBR previous annual earnings announcement was published on Apr 30, 2024

Next Annual Earnings Report Date

N/A
CSBR next annual earnings announcement has not yet been scheduled

OtherCSBRprofitabilitymetrics:

Annual Revenue

$50.16 M
CSBR annual revenue is $50.16 million

Annual Net Income

-$7.28 M
CSBR annual net profit is -$7.28 million

Annual EPS

-$0.54
CSBR annual earnings per share is -$0.54

Annual ROA

-24.08%
CSBR annual return on assets is -24.08%

Quarterly ROE

66.22%
-257.30%-79.53%

October 31, 2024

Summary

Performance

3-Month Change

-79.53%

1-Year Change

+131.43%

3-Year Change

+131.43%

5-Year Change

+131.43%

CSBR Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

89.77%
CSBR quarterly return on equity is higher than 89.77% of companies in Healthcare sector

High & Low

All-time High

3397.27%
CSBR quarterly return on equity is currently -98.05% below its historical high of 3397.27%

3-Year Low

-1362.04%

Earnings dates

Last Quarterly Earnings Report Date

Oct 31, 2024
CSBR previous earnings announcement was published on Oct 31, 2024

Next Quarterly Earnings Report Date

Mar 12, 2025
CSBR next earnings announcement is scheduled for Mar 12, 2025

OtherCSBRprofitabilitymetrics:

Quarterly Revenue

$13.49 M
CSBR quarterly revenue is $13.49 million

Quarterly Net Income

$728.00 K
CSBR quarterly net profit is $728.00 thousand

Quarterly EPS

$0.05
CSBR quarterly earnings per share is $0.05

Quarterly ROA

-2.28%
CSBR quarterly return on assets is -2.28%

ROE Formula

ROE =  Net Income
Shareholders Equity ✕ 100%

Annual ROE

-532.46%
CSBR annual return on equity is -532.46%

Annual Net Income

-$7.28 M
CSBR annual net profit is -$7.28 million

Annual Shareholders Equity

-$1.90 M
CSBR annual stockholders equity is -$1.90 million

CSBR ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-585.3%+131.4%
3 y3 years-9312.1%+131.4%
5 y5 years-4762.5%+131.4%

CSBR ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-8131.1%at low-79.5%+104.9%
5 y5-year-4762.5%at low-79.5%+104.9%
alltimeall time-864.8%+75.3%-98.0%+100.4%

Champions Oncology ROE History

DateAnnualQuarterly
Oct 2024
-
66.22%(-79.5%)
Jul 2024
-
323.52%(-123.8%)
Apr 2024
-532.46%(+585.3%)
-1362.04%(+225.9%)
Jan 2024
-
-417.94%(+98.3%)
Oct 2023
-
-210.71%(+76.5%)
Jul 2023
-
-119.37%(+74.3%)
Apr 2023
-77.70%(-1271.9%)
-68.48%(+91.3%)
Jan 2023
-
-35.80%(-3058.7%)
Oct 2022
-
1.21%(-74.1%)
Jul 2022
-
4.67%(-29.5%)
Apr 2022
6.63%(+14.7%)
6.62%(+142.5%)
Jan 2022
-
2.73%(-47.2%)
Oct 2021
-
5.17%(+217.2%)
Jul 2021
-
1.63%(-70.5%)
Apr 2021
5.78%(-110.1%)
5.52%(-127.9%)
Jan 2021
-
-19.79%(-46.4%)
Oct 2020
-
-36.89%(-5.5%)
Jul 2020
-
-39.02%(-46.4%)
Apr 2020
-57.05%(-599.6%)
-72.86%(+837.7%)
Jan 2020
-
-7.77%(-83.1%)
Oct 2019
-
-45.98%(-18.0%)
Jul 2019
-
-56.06%(-732.0%)
Apr 2019
11.42%(-101.6%)
8.87%(-138.0%)
Jan 2019
-
-23.37%(-492.1%)
Oct 2018
-
5.96%(-106.5%)
Jul 2018
-
-91.95%(-80.8%)
Apr 2018
-732.51%(-66.1%)
-479.84%(+5.0%)
Jan 2018
-
-457.06%(+25.3%)
Oct 2017
-
-364.70%(+32.6%)
Jul 2017
-
-275.00%(-27.6%)
Apr 2017
-2157.99%(+757.0%)
-379.90%(+18.0%)
Jan 2017
-
-322.08%(+4.0%)
Oct 2016
-
-309.55%(-3.7%)
Jul 2016
-
-321.47%(+26.5%)
Apr 2016
-251.80%(+7.8%)
-254.05%(-28.8%)
Jan 2016
-
-356.94%(-28.0%)
Oct 2015
-
-495.52%(-33.3%)
Jul 2015
-
-743.18%(-35.5%)
Apr 2015
-233.48%(+71.4%)
-1152.20%(-58.3%)
Jan 2015
-
-2762.74%(+506.9%)
Oct 2014
-
-455.25%(+90.7%)
Jul 2014
-
-238.71%(+64.5%)
Apr 2014
-136.23%(+13.6%)
-145.11%(+28.0%)
Jan 2014
-
-113.37%(-40.4%)
Oct 2013
-
-190.10%(-47.6%)
Jul 2013
-
-362.93%(-21.2%)
Apr 2013
-119.92%
-460.85%(-113.6%)
Jan 2013
-
3397.27%(+1417.7%)
Oct 2012
-
223.85%(-38.5%)
DateAnnualQuarterly
Jul 2012
-
364.14%(-59.2%)
Apr 2012
-597.31%(+25.4%)
892.73%(+70.0%)
Jan 2012
-
525.04%(-103.1%)
Oct 2011
-
-16.99 K%(+2414.0%)
Jul 2011
-
-675.77%(+129.4%)
Apr 2011
-476.44%(+184.7%)
-294.64%(+198.2%)
Jan 2011
-
-98.79%(-37.7%)
Oct 2010
-
-158.56%(-31.5%)
Jul 2010
-
-231.64%(-3.9%)
Apr 2010
-167.36%(+107.3%)
-241.09%(-4.6%)
Jan 2010
-
-252.62%(+30.9%)
Oct 2009
-
-192.94%(+51.0%)
Jul 2009
-
-127.80%(+71.7%)
Apr 2009
-80.75%(+231.6%)
-74.43%(+24.4%)
Jan 2009
-
-59.83%(+144.4%)
Oct 2008
-
-24.48%(-6.8%)
Jul 2008
-
-26.26%(-15.1%)
Apr 2008
-24.35%(-137.4%)
-30.92%(-143.4%)
Jan 2008
-
71.25%(-141.4%)
Oct 2007
-
-171.99%(-111.9%)
Jul 2007
-
1449.25%(+3439.9%)
Apr 2007
65.15%(+43.9%)
40.94%(+199.5%)
Jan 2007
-
13.67%(-26.7%)
Oct 2006
-
18.64%(-7.4%)
Jul 2006
-
20.14%(-63.1%)
Apr 2006
45.29%(-32.6%)
54.52%(-11.5%)
Jan 2006
-
61.58%(-9.7%)
Oct 2005
-
68.22%(-33.7%)
Jul 2005
-
102.93%(+17.4%)
Apr 2005
67.20%(+25.0%)
87.70%(+19.8%)
Jan 2005
-
73.21%(-21.9%)
Oct 2004
-
93.70%(+65.1%)
Jul 2004
-
56.75%(+70.6%)
Apr 2004
53.77%(-22.8%)
33.27%(-70.1%)
Jan 2004
-
111.43%(+6.5%)
Oct 2003
-
104.62%(+44.4%)
Jul 2003
-
72.45%(-41.8%)
Apr 2003
69.62%(-134.5%)
124.57%(-48.9%)
Jan 2003
-
243.85%(-112.7%)
Oct 2002
-
-1922.46%(+299.1%)
Jul 2002
-
-481.65%(+176.4%)
Apr 2002
-201.73%(+55.4%)
-174.26%(-5.6%)
Jan 2002
-
-184.52%(+2.2%)
Oct 2001
-
-180.56%(+16.1%)
Jul 2001
-
-155.57%(+39.3%)
Apr 2001
-129.83%(-2346.2%)
-111.68%(+80.2%)
Jan 2001
-
-61.97%(+212.3%)
Oct 2000
-
-19.84%(+1904.0%)
Jul 2000
-
-0.99%
Apr 2000
5.78%
-

FAQ

  • What is Champions Oncology annual return on equity?
  • What is the all time high annual ROE for Champions Oncology?
  • What is Champions Oncology annual ROE year-on-year change?
  • What is Champions Oncology quarterly return on equity?
  • What is the all time high quarterly ROE for Champions Oncology?
  • What is Champions Oncology quarterly ROE year-on-year change?

What is Champions Oncology annual return on equity?

The current annual ROE of CSBR is -532.46%

What is the all time high annual ROE for Champions Oncology?

Champions Oncology all-time high annual return on equity is 69.62%

What is Champions Oncology annual ROE year-on-year change?

Over the past year, CSBR annual return on equity has changed by -454.76% (-585.28%)

What is Champions Oncology quarterly return on equity?

The current quarterly ROE of CSBR is 66.22%

What is the all time high quarterly ROE for Champions Oncology?

Champions Oncology all-time high quarterly return on equity is 3397.27%

What is Champions Oncology quarterly ROE year-on-year change?

Over the past year, CSBR quarterly return on equity has changed by +276.93% (+131.43%)